New startup company eGenesis looks to pigs for transplant organs

Karen Weintraub, 16 March 2017, MIT Technology Review.

A new startup company, eGenesis, from Harvard Medical School’s George Church, is working to modify pigs to create organs suitable for transplant into humans.  The startup will be taking a two-pronged approach; one line of pigs will be developed to lack risky viruses and a second line will be modified to have a “humanized” immune system.  The two lines will then be merged into a single line for further study.  While this approach holds promise, years of testing and clinical trials will be needed before widespread adoption.

Author: Advanced Analytical

Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare.

Leave a Reply